Please upgrade your browser.
With 3.2 million members, Blue Shield appears to be the largest health insurer so far to stop covering Avastin...
RENCAREX® has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) of its investigational compound RENCAREX® which is currently undergoing the pivotal Phase III trial ARISER for the adjuvant treatment of patients with non-metastatic clear cell Renal Cell Carcinoma (ccRCC) at high risk of relapse after surgery.
Learn how the members of Team KCA are supporting the Kidney Cancer Association by running in the 2011 Bank of America Chicago Marathon.
The kidneys are important organs with many functions in the body, including producing hormones, absorbing minerals, and filtering blood and urine. While they are important and kidney failure can be fatal, a human only needs one to survive.
...a new study suggests it could also increase your risk of having or dying from cancer.
New cancer report: Targeted therapies a success
NCCN Categories of Evidence and Consensus
Nonprofits are gearing up to fight President Obamas plan to pay for his jobs bill in part by limiting charitable deductions.
Heavy use of some over-the-counter pain medication linked to kidney cancer.
|Powered by NeonCRM|